ロード中...
A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency
Antiretroviral therapy for HIV-1 infection/AIDS has significantly extended the life expectancy of HIV-1-infected individuals and reduced HIV-1 transmission at very high rates. However, certain individuals who initially achieve viral suppression to undetectable levels may eventually suffer treatment...
保存先:
| 出版年: | eLife |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
eLife Sciences Publications, Ltd
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5644950/ https://ncbi.nlm.nih.gov/pubmed/29039736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7554/eLife.28020 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|